Monopar Therapeutics Competitors and Similar CompaniesClear all
Monopar Therapeutics's competitors and similar companies include Innate Pharma, OncoDNA, A2 Biotherapeutics and Turnstone Biologics.
 Monopar Therapeutics Monopar Therapeutics is a biopharmaceutical company focused on developing innovative drugs and drug combinations to improve clinical outcomes for cancer patients. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. |  OncoDNA OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients. |  A2 Biotherapeutics A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients. | ||
Founding Date | Founding Date 2014 | Founding Date 1999 | Founding Date 2012 | Founding Date 2018 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Wilmette, US HQ | Locations Marseille, FR HQ Rockville, US | Locations Charleroi, BE HQ | Locations Agoura Hills, US HQ | Locations San Diego, US HQ Ottawa, CA |
Employees | Employees 4 | Employees 181 | Employees 502% increase | Employees 1255% decrease | Employees 112 |
Valuation ($) | Valuation ($) 57.1 m | Valuation ($) 148.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11.6 m |
Financial | |||||
Net income | Net income ($13.6m) (FY, 2025) | Net income (€49.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($70.8m) (FY, 2024) |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products 1 (Sep, 2019) | Phase I Trials Products 3 (Q2, 2019) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 1 (Sep, 2019) | Phase II Trials Products 5 (Q2, 2019) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Pre-Clinical Phase Products | Pre-Clinical Phase Products 1 (FY, 2018) | Pre-Clinical Phase Products 7 (Q2, 2019) | Pre-Clinical Phase Products N/A | Pre-Clinical Phase Products N/A | Pre-Clinical Phase Products N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 20.6m (over 6 years ago) | Latest funding round $ 71.5m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 2.1m | Total funding raised $ 94.1m | Total funding raised $ 29.8m | Total funding raised $ 128.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View companyOncoDNA
HQ
Charleroi, BE
Employees
50↑ 2% increase
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
View companyA2 Biotherapeutics
HQ
Agoura Hills, US
Employees
125↓ 5% decrease
A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients.
View company
Turnstone Biologics
HQ
San Diego, US
Employees
112
Turnstone Biologics is an immuno-oncology company.
View company